NDC 80425-0239-01 - Moxifloxacin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0239
- Requested NDC
- 80425-0239-01
- Package NDCs from labels
- 80425-0239-1, 80425-0239-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Moxifloxacin - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0239-1 | Moxifloxacin | 3 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 3 | 3 | |
| 80425-0239-1 | Moxifloxacin | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0239 | MOXIFLOXACIN SOLUTION/ DROPS [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 3 | Current NDC, 2 package rows | 20250102_f19fa89e-9f5d-4eed-e053-2995a90ac3ce.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0239-1 | ML - Milliliter | 80425-0239 | b22cdef2-08d4-45f9-aadc-dfc84bca01b7 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Moxifloxacin Hydrochloride Tablets, 400 mg | MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG | REMEDYREPACK INC. | bdb3f89a-01e7-411d-b071-48e87def0873 | 2026-09-04 | Boxed warning, Warnings, Adverse reactions | B8956S8609 |
| MOXIFLOXACIN | MOXIFLOXACIN | A-S Medication Solutions | f702e112-b037-4e50-ac30-b1d27fc0e30e | 2026-08-05 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | Redpharm Drug | 51d45346-5506-d2c9-e063-6394a90ae6bb | 2026-05-15 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin ophthalmic solution | MOXIFLOXACIN | Redpharm Drug | 4fb55f17-d9db-8148-e063-6394a90a8216 | 2026-04-18 | Warnings, Adverse reactions | 403818 |
| VIGAMOX | MOXIFLOXACIN HYDROCHLORIDE | Harrow Eye, LLC | 12053b08-7e66-c6f3-e063-6394a90a9cd9 | 2026-01-22 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin | MOXIFLOXACIN | Redpharm Drug | 301eef74-16db-14aa-e063-6294a90ac8ff | 2025-12-23 | Warnings, Adverse reactions | 403818 B8956S8609 |
| Moxifloxacin | MOXIFLOXACIN | Golden State Medical Supply, Inc. | f9dff08a-edb2-86de-e053-6394a90a1043 | 2025-12-17 | Warnings, Adverse reactions | ANDA090080 403818 B8956S8609 |
| MOXIFLOXACIN | MOXIFLOXACIN | Lupin Pharmaceuticals, Inc. | d66f080b-da56-4473-8785-920d9700f72d | 2025-10-13 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin | MOXIFLOXACIN | Lupin Pharmaceuticals, Inc. | ae77e219-8af9-4aa4-96d3-05c9726a1d3c | 2025-10-13 | Warnings, Adverse reactions | 403818 B8956S8609 |
| Moxifloxacin Hydrochloride Tablets, 400 mg | MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG | PD-Rx Pharmaceuticals, Inc. | 5c2a9116-d6e4-429e-88bb-bb6bfedac2f0 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | B8956S8609 |
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | Asclemed USA, Inc. | 8f92f110-32d6-4d0c-a415-7a9a4cafb9b8 | 2025-04-19 | Warnings, Adverse reactions | 403818 |
| STRENZA PLUS | MOXIFLOXACIN 0.5%, BROMFENAC 0.09%, PREDNISOLONE ACETATE 1% | Brisk Pharmaceuticals | 2df9064c-0527-4c21-e063-6294a90a56d8 | 2025-02-12 | 403818 | |
| Moxifloxacin ophthalmic solution | MOXIFLOXACIN | Lifestar Pharma LLC | ca19b837-8e80-408f-af7b-b0464f20c0c3 | 2025-01-30 | Warnings, Adverse reactions | 403818 |
| MOXIFLOXACIN | MOXIFLOXACIN | Direct Rx | d771e69b-7d9b-13fa-e053-2995a90ac161 | 2025-01-21 | Warnings, Adverse reactions | 403818 B8956S8609 |
| MOXIFLOXACIN | MOXIFLOXACIN | Direct Rx | d9b6a460-6377-76d0-e053-2995a90a3d05 | 2025-01-21 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin | MOXIFLOXACIN | Advanced Rx Pharmacy of Tennessee, LLC | f19fa89e-9f5d-4eed-e053-2995a90ac3ce | 2024-12-31 | Warnings, Adverse reactions | ANDA090080 80425-0239-1 80425-0239 80425023901 403818 2a9aa671-d0a2-2254-e063-6294a90a9f79 f19fa89e-9f5d-4eed-e053-2995a90ac3ce B8956S8609 |
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | Somerset Therapeutics, LLC | f7c68d49-8c61-4bde-a880-4d78568e5aa0 | 2024-11-25 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin | MOXIFLOXACIN | Bryant Ranch Prepack | 1cc031d7-0766-41c0-b5b3-35119c850e23 | 2024-10-04 | Warnings, Adverse reactions | ANDA090080 403818 B8956S8609 |
| Moxifloxacin ophthalmic solution | MOXIFLOXACIN OPHTHALMIC SOLUTION | Alembic Pharmaceuticals Limited | fee8323d-bcb0-4f49-a06d-2ed597a7b2ac | 2024-04-19 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin ophthalmic solution | MOXIFLOXACIN OPHTHALMIC SOLUTION | Alembic Pharmaceuticals Inc. | 0f2cdbf6-bc74-4b22-b795-23ace89894b3 | 2024-04-19 | Warnings, Adverse reactions | 403818 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.